Tim Studt

The 3 mm Multi-Nuclear Inverse (MNI) CryoProbe is a Nuclear Magnetic Resonance (NMR) detector “combining the highest sensitivity and versatility,” according to the R&D 100 2025 team at Bruker who developed it.

The R&D World Index (RDWI) slid this week even as several companies rolled out big new R&D projects. For the week ending May 9, 2025, the index closed at 3,773.11, down 3.85% (–151.24 points). Sixteen of the 25 members fell. Eli Lilly & Co. was the biggest laggard (–10.81%) despite breaking ground on a huge research-and-manufacturing district. On the upside, General Motors gained 4.86% and Microsoft inched up 0.79%. Outside the market swoon, action was brisk.

Market volatility dominated the R&D landscape following President Trump’s tariff actions. The R&D World Index (RDWI) for the week ending April 4, 2025, reflected the initial shock, closing down a significant -9.28% at 3,506.27, with significant losses across all 25 member companies. Auto companies have been especially hard hit. To date, losses range from –1.44% for Ford to –14.21% for Stellantis. This uniform drop marks the first time this occurred in the Index’s history.